Valuation: Zoetis Inc.

Capitalization 79.93B 76.23B 70.69B 62.7B 113B 6,777B 126B 878B 325B 2,787B 300B 294B 12,188B P/E ratio 2024 *
32.7x
P/E ratio 2025 * 29x
Enterprise value 84.15B 80.26B 74.42B 66.01B 119B 7,135B 132B 924B 342B 2,934B 316B 309B 12,832B EV / Sales 2024 *
9.08x
EV / Sales 2025 * 8.62x
Free-Float
89.78%
Yield 2024 *
0.96%
Yield 2025 * 1.06%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.26%
1 week+1.06%
Current month+1.10%
1 month+0.58%
3 months-6.75%
6 months-0.77%
Current year-10.23%
More quotes
1 week
174.41
Extreme 174.41
179.78
1 month
170.75
Extreme 170.75
181.40
Current year
144.80
Extreme 144.8
200.53
1 year
144.80
Extreme 144.8
201.92
3 years
124.15
Extreme 124.1483
249.27
5 years
90.14
Extreme 90.14
249.27
10 years
37.73
Extreme 37.73
249.27
More quotes
Director TitleAgeSince
Chief Executive Officer 52 31/12/2019
Director of Finance/CFO 52 31/05/2021
Chief Tech/Sci/R&D Officer - 31/10/2020
Manager TitleAgeSince
Chairman 66 30/06/2012
Director/Board Member 66 31/12/2012
Chairman 71 25/06/2013
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.26%+1.06%-6.49%-23.45%79.93B
+0.89%+2.29%-1.42%-55.20%6.19B
+1.36%+2.37%+40.43%-8.11%4.14B
-0.15%+3.34%+9.81%-26.75%2.85B
-0.24%-0.73%+62.49%-38.20%1.95B
+1.70%-3.87%+19.53%-10.18%1.29B
+2.22%+3.80%-35.80%-36.57%1.04B
-0.26%+2.16%-16.84%-40.78%998M
-1.42%-2.30%-14.98%-42.06%964M
+3.68%+1.40%+118.41%+24.47%970M
Average +0.80%+0.72%+17.52%-25.68% 10.03B
Weighted average by Cap. +0.37%+1.11%-1.38%-25.01%
See all sector performances

Financials

2024 *2025 *
Net sales 9.27B 8.84B 8.2B 7.27B 13.11B 786B 14.56B 102B 37.71B 323B 34.82B 34.05B 1,413B 9.73B 9.28B 8.6B 7.63B 13.76B 825B 15.28B 107B 39.58B 339B 36.55B 35.74B 1,484B
Net income 2.46B 2.35B 2.18B 1.93B 3.48B 209B 3.87B 27.06B 10.02B 85.9B 9.25B 9.05B 376B 2.72B 2.59B 2.4B 2.13B 3.84B 230B 4.27B 29.85B 11.05B 94.73B 10.21B 9.98B 414B
Net Debt 4.22B 4.03B 3.73B 3.31B 5.97B 358B 6.63B 46.38B 17.17B 147B 15.86B 15.51B 644B 3.94B 3.76B 3.48B 3.09B 5.57B 334B 6.19B 43.26B 16.02B 137B 14.79B 14.47B 600B
More financial data * Estimated data
Logo Zoetis Inc.
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%); - livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%); - other (1.1%). Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%). At the end of 2022, the group has 29 production sites worldwide. The United States accounts for 53.4% of net sales.
Employees
14,100
More about the company
Date Price Change Volume
11/12/24 177.17 $ +0.26% 1,782,356
10/12/24 176.71 $ -0.81% 1,678,161
09/12/24 178.15 $ +0.96% 2,387,445
06/12/24 176.46 $ +0.97% 2,551,210
05/12/24 174.77 $ -0.31% 2,441,959

Delayed Quote Nyse, December 11, 2024 at 09:00 pm

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B+
surperformance-ratings-light-chart ZOETIS-INCMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
177.17USD
Average target price
214.22USD
Spread / Average Target
+20.91%
Consensus

Quarterly revenue - Rate of surprise